Data from multiple sources indicate that most of the growth in private funding in life sciences has been driven by late-stage financings and crossover investors rather than by traditional venture capital.

There has been limited to no support to finance early stage life sciences companies either due to lack of access or belief in the technology's growth potential and commercialization.

BioHubble aims to address this market gap by providing fluid, transparent and actionable information access to both investors and biopreneurs.

Investors may be early stage or angels who are willing to take a risk and finance a promising early stage life sciences start-up.